icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research icrowd research

3D Printed Organ Market Size Worth $6.8 billion By 2030: IndustryARC

Feb 26, 2024 10:00 PM ET

3D Printed Organ Market Size Worth $6.8 billion By 2030: IndustryARC

The Global 3D Printed Organ Market size is predicted to reach $6.8 billion by 2030, growing at a CAGR of 18.0 % during the forecast period 2024-2030. 3D-printed organs refer to artificially created organs using additive manufacturing techniques like 3D bioprinting. This process involves layer-by-layer deposition of biomaterials and cells to construct functional tissues or organs.

It aims to replicate the intricate structure and function of human organs for transplantation, research, or therapeutic purposes, regenerative medicine is a significant driver for 3D bioprinting. It aims to restore damaged tissues or organs by using engineered constructs.

which is anticipated to propel the growth of the 3D-Printed Organ Market for the forecast period finds IndustryARC in its recent report, titled “3D-Printed Organ Market Size, Share & Trends Analysis Report – By Organ Type, (Heart, Liver, Kidney, Lung, Skin, Bone, Ear, Eye, Others), By Technology, (Extrusion-Based 3D Printing, Laser-Assisted Printing, Inkjet Printing, Stereolithography, Magnetic Levitation, Laser Based, Others), By Material (Biological Materials (Bioinks), Synthetic Polymers, Hydrogels, Ceramics, Metals, Biomaterials, Others), By Application, (Transplantation, Research & Drug Testing, Disease Modeling, Regenerative Medicine, Medical Training & Education, Others), By End User, (Hospitals & Clinics, Research Institutes & Laboratories, Pharmaceutical Companies, Academic Institutions, Others), By Geography – Global Opportunity Analysis & Industry Forecast, 2024-2030.”

Request Sample Research Report:

APAC to Register Highest Growth:

Geographically, in the global 3D-Printed Organ Market, APAC is analyzed to grow with the highest CAGR of 19.5% during the forecast period 2024-2030. The 3D-printed organ market is witnessing substantial growth globally, with the Asia-Pacific (APAC) region poised to register the highest expansion. As of May 2022, more than 10,000 people were waiting for an organ transplant, according to data from the Taiwan Organ Registry and Sharing Center which is anticipated to fuel the growth of the market. Several factors contribute to APAC’s remarkable growth in this domain.

The region’s increasing investments in healthcare technologies, supportive government initiatives, rising healthcare infrastructure, and the presence of a significant patient pool contribute to this surge. Furthermore, technological advancements and collaborations between research institutions and industry players drive innovation, fostering the adoption of 3D bioprinting for organ manufacturing and medical implants. The market for 3D-printed organs in the APAC region is on an upward trajectory, reflecting an increased focus on addressing organ shortages and advancing personalized medicine. As APAC continues to demonstrate significant advancements in healthcare and technology, its role in the 3D-printed organ market is expected to strengthen.

3D-Printed Organ Market 2024-2030: Scope of the Report

Report Metric


Base Year Considered


Forecast Period




Market Size in 2030

$6.8 billion

Segments Covered

Organ Type, Technology, Material, Application, End User and Region

Geographies Covered

North America, South America, Europe, APAC, Middle East & Africa

Key Market Players

  1. Organovo Holding, Inc.
  2. 3Dynamics Systems Ltd
  3. Cyfuse Biomedical K.K.
  4. Aspect Biosystems Ltd.
  5. Stratasys Ltd.
  6. Voxeljet A.G.
  7. Materialise N.V.
  8. Envision TEC
  9. Advanced Solutions, Inc.,
  10. Digilab Inc

Get Access to Full Research Report:

3D-Printed Organ Market Report – Key Takeaways:

Pharmaceutical Companies Segment to Register the Highest Share

In the 3D-Printed Organ Market Analysis, the pharmaceutical companies’ segment is dominating market in 2023. Pharmaceutical entities engage in collaborations with biotech firms and research institutions to advance 3D bioprinting techniques, aiming to revolutionize drug testing, tissue engineering, and regenerative medicine. As per EFPIA, in 2022 North America accounted for 52.3% of world pharmaceutical sales compared with 22.4% for Europe.

These companies utilize 3D bioprinting for drug development, particularly in creating organ-on-a-chip models, allowing for more accurate drug testing with reduced reliance on animal models. Some pharmaceutical companies diversify their portfolio by venturing into the development of 3D-printed medical devices, implants, or personalized treatments to cater to specific patient needs. The involvement of pharmaceutical companies significantly shapes the 3D bioprinting market landscape, contributing to market growth and fostering innovations in regenerative medicine and healthcare.

Bone is the Fastest Growing Segment in the Market

In the 3D-Printed Organ Market Analysis, the Bone segment is estimated to grow with the highest CAGR during the forecast period 2024-2030. Bone tissue engineering harnesses 3D printing technology to create customized implants and prostheses. It addresses bone defects, fractures, and complex skeletal injuries by fabricating intricate structures that mimic the natural bone matrix.

3D-printed bone implants offer high biocompatibility and precision, enhancing their acceptance and integration within the body. The technology allows for tailoring implants to patient-specific needs, ensuring optimal fit and function. The global 3D-printed organs market projects substantial growth, and the bone segment is anticipated to be a significant contributor due to the rising demand for orthopedic implants and advancements in bioprinting techniques.

The rapid evolution of 3D-printed bone implants signifies their transformative impact on orthopedic care, promising better patient outcomes, reduced surgical complications, and improved quality of life for individuals with bone-related ailments or injuries.

Increasing geriatric population with chronic respiratory diseases

The 3D-printed organs sector is witnessing substantial growth, propelled by the escalating prevalence of chronic respiratory diseases among the geriatric population. With a global increase in life expectancy, the geriatric demographic, particularly those aged 65 and above, is expanding. This population segment encounters a higher incidence of chronic respiratory conditions, including chronic obstructive pulmonary disease (COPD), emphysema, and bronchitis.

Chronic respiratory ailments have become a significant health concern among the elderly, leading to an increased demand for advanced treatments and organ replacements. These conditions often necessitate lung transplants or supportive interventions, aligning with the potential of 3D-printed organs to address organ shortages and provide tailored solutions.

The integration of 3D bioprinting technologies into healthcare is addressing the rising demand for innovative treatments.

Purchase this Premium Report:

Key Opportunity Analysis:

Advancements in Biomaterials

The field of 3D-printed organs is propelled by remarkable advancements in biomaterials, contributing significantly to the innovation and progress within this sector. Biomaterials for 3D printing have evolved remarkably, offering a diverse range of options compatible with biological systems. This includes biocompatible polymers, hydrogels, bioinks, and biodegradable materials that mimic natural tissues.

Advances focus on developing biomaterials that closely resemble the mechanical, structural, and biological properties of native tissues. These materials enable precise replication of tissue architecture and functionalities, crucial for successful organ bioprinting. Biomaterial advancements have led to the creation of bioinks capable of supporting cellular growth and differentiation.

These engineered materials facilitate the precise layer-by-layer construction of complex organ structures with embedded cells, fostering tissue maturation and functionality.

Development of new bioinks

Ongoing research is dedicated to developing advanced bioinks that serve as printable materials embedding living cells. These bioinks mimic the extracellular matrix, providing a supportive environment for cell growth, differentiation, and organ development.

New bioinks emphasize biocompatibility, ensuring that they are non-toxic and compatible with living tissues. Additionally, these bioinks are designed to support cellular activities, fostering the creation of functional tissues and organs.

Advancements in bioink formulations enable precise control over the printing process, facilitating the creation of complex structures with intricate cellular compositions. Tailoring bioinks to specific tissues or organs enhances precision in replicating natural functions.

New bioinks serve as the cornerstone for 3D-printed organ development, offering enhanced biocompatibility, precise cellular control, and tailored functionalities crucial for replicating natural tissues and advancing organ replacement therapies.

If you have any questions, please feel free to contact our experts at:

The Report also Covers the Following Areas:

3D-Printed Organ Market Size and Forecast
3D-Printed Organ Market Trends
3D-Printed Organ Market Analysis by Deployment Type

3D-Printed Organ Market 2024-2030: Key Highlights

CAGR of the market during the forecast period 2024-2030
Value Chain analysis of key stake holders
Detailed analysis of market drivers and opportunities during the forecast period
3D-Printed Organ Market size estimation and forecast
Analysis and predictions on end users’ behavior and upcoming trends
Competitive landscape and Vendor market analysis including offerings, developments, and financials
Comprehensive analysis of challenges and constraints in the 3D-Printed Organ Market.

Covid and Ukrainian Crisis Impact:

The 3D-Printed Organ Market has encountered fluctuations due to the COVID-19 pandemic. The COVID-19 pandemic brought both challenges and opportunities to the 3D-printed organ market. While disruptions impacted supply chains, the industry showcased resilience and adaptability, fueling innovations and promising growth in the healthcare and medical sectors. The pandemic spurred positive impacts within the healthcare 3D printing sector, notably facilitating rapid production of PPE like face masks and shields. However, it disrupted supply chains, affecting the 3D organ printing market, and leading to fluctuations. The market’s response to COVID-19 showcased the versatility and adaptability of 3D printing technology. Although the pandemic presented hurdles, the industry’s resilience and innovation underscore its potential for transformative growth in the coming years.

The Russian invasion of Ukraine in 2023, The conflict’s geopolitical implications and global economic shifts due to the Russia-Ukraine War have led to uncertainties and disruptions in various industries, including laser marking machines. The conflict has introduced geopolitical tensions affecting global trade, supply chains, and economic stability. This instability has triggered fluctuations in the demand and supply of laser marking machines, impacting market growth and strategic planning. The conflict’s ongoing nature and its implications for global geopolitics and economics emphasize the need for ongoing assessment and adaptation within the 3D-Printed Organ Market. This includes monitoring geopolitical tensions’ influence on trade, supply chains, and market strategies.

To Get a Customized Industry Analysis, Speak with our Research Analyst:

List of Key Market Players in 3D-Printed Organ Market:

The key companies profiled in the 3D-Printed Organ Market Report are listed below:

  1. Organovo Holding, Inc.
  2. 3Dynamics Systems Ltd
  3. Cyfuse Biomedical K.K.
  4. Aspect Biosystems Ltd.
  5. Stratasys Ltd.
  6. Voxeljet A.G.
  7. Materialise N.V.
  8. Envision TEC
  9. Advanced Solutions, Inc.,
  10. Digilab Inc
  11. Medprin Biotech GmbH
  12. REGEMAT 3D S.L
  13. Cellbricks
  14. Xilloc Medical Int B.V.
  15. Ossiform

Related Reports:

Printed Sensors Market– The Printed Sensors Market size is projected to grow at a CAGR of 7.3% from 2023 to 2030, with the evolution and expansion of the automotive temperature sensor marketplace, this rising concern can be controlled.

Organs-on-chips Market – The Organs-on-chips Market size is projected to grow at a CAGR of 827.8% during the forecast period from 2023 to 2030. growing focus on mimicking physiological functions for various organs, promising substantial growth and innovation opportunities.

Artificial Organs & Bionic Implants Market – The Artificial Organs & Bionic Implants Market size is growing at a CAGR of 7.2% during the forecast period 2023 to 2030. increasing investment in research and development, are also contributing to the growth of this market.

About IndustryARC™:

IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets. 

IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format which assists an intelligent and informed decision-making process.

Contact Us:

Mr. Venkat Reddy


Email: [email protected]

USA: (+1) 518-282-4727


Follow us on: LinkedIn | Facebook | Twitter

Tags: , , , , , , , ,

See Campaign:

Contact Information:

Mr. Venkat Reddy IndustryARC Email: [email protected] USA: (+1) 518-282-4727


BNN, Extended Distribution, iCN Internal Distribution, Wire, Research Newswire, English